Beta 40 and 42 in a Mouse Model of Alzheimer’s Disease», Nutrition & Metabolism 2 (October 2005).
8. Matthew K. Taylor et al., «Feasibility and Efficacy Data from a Ketogenic Diet Intervention in Alzheimer’s Disease», Alzheimer’s & Dementia: Translation Research & Clinical Interventions 4 (2018): 28–36.
9. Rosebud O. Roberts, L. A. Roberts, Y. E. Geda, et al., «Relative Intake of Macronu– trients Impacts Risk of Mild Cognitive Impairment or Dementia», Journal of Alzheimer’s Disease 32 (January 2012): 329–339.
10. Steven C. Vlad et al., «Protective Effects of NSAIDs on the Development of Alzheimer Disease», Neurology 70 (May 2008): 1672–1677.
11. Markus Bock, Andreas Michalsen, and Friedemann Paul, «Ketogenic Diet and Prolonged Fasting Improve Health-Related Quality of Life and Lipid Profiles in Multiple Sclerosis – A Randomized Controlled Trial» (Conference Paper, ECTRIMS 2015, Barcelona, October 2015).
12. T. E. Cullingford, «The Ketogenic Diet; Fatty Acids, Fatty Acid-Activated Receptors and Neurological Disorders», Prostaglandins, Leukotrines and Essential Fatty Acids 70 (March 2004): 253–264.
13. Mithu Storoni and Gordon T. Plant, «The Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple Sclerosis», Multiple Sclerosis International (December 2015).
14. T. B. VanItallie, C. Nonas, A. Di Rocco, K. Boyar, K. Hyams, and S. B. Heymsfield, «Treatment of Parkinson Disease with Diet-Induced Hyperketonemia: A Feasibility Study», Neurology 64 (February 2005): 728–730.
15. O. El-Rashidy, F. El-Baz, Y. El-Gendy, R. Khalaf, D. Reda, and K. Saad, «Ketogenic Diet versus Gluten Free Casein Free Diet in Autistic Children: A Case-Control Study», Metabolic Brain Disease 32 (December 2017): 1935–1941.
16. E. C. Bostrok, Kenneth C. Kirkby, and Bruce V. M. Taylor, «The Current Status of the Ketogenic Diet in Psychiatry», Frontiers in Psychiatry 8 (March 2017).
17. C. Di Lorenzo, G. Coppola, G. Sirianni, et al., «Migraine Improvement during Short Lasting Ketogenesis: A Proof-of-Concept Study», European Journal of Neurology 22 (January 2015): 170–177.
18. Cherubino Di Lorenzo, Gianluca Coppola, Davide Di Lenola, et al., «Efficacy of Modified Atkins Ketogenic Diet in Chronic Cluster Headache: An Open-Label, Single-Arm Clinical Trial», Frontiers in Neurology 9 (February 2018).
19. Justin Sonnenburg and Erica Sonnenburg, «Gut Feelings – the ‘Second Brain’ in Our Gastrointestinal Systems», Scientific American, May 1, 2015, https: / / www.scientificamerican.com / ar ticle / g ut– feelings– the– second– brain-in-our– gastrointestinal– systems-excerpt /.
20. Virginia Chaidez, Robin L. Hansen, and Irva Hertz-Picciotto, «Gastrointestinal Problems in Children with Autism, Developmental Delays or Typical Development», Journal of Autism and Developmental Disorders 44 (May 2014): 1117–1127.
21. D. Liu, Z. Wang, Z. Gao, et al., «Effects of Curcumin on Learning and Memory Deficits, BDNF, and ERK Protein Expression in Rats Exposed to Chronic Unpredictable Stress», Behavioural Brain Research 271 (September 2014): 116–121.
22. J. Sanmukhani, V. Satodia, J. Trivedi, et al., «Efficacy and Safety of Curcumin in Major Depressive Disorder: A Randomized Controlled Trial», Phytotherapy Research 28 (April 2014): 579–585.
23. David Kennedy, E. L. Wightman, J. L. Reay, et al., «Effects of Resveratrol on Cerebral Blood Flow Variables and Cognitive Performance in Humans: A Double-Blind, Placebo-Controlled, Crossover Investigation», American Journal of Clinical Nutrition 91 (June 2010): 1590–1597.
24. Esther M. Blessing, M. M. Steenkamp, J. Manzanares, and C. R. Marmar, «Cannabidiol as a Potential Treatment for Anxiety Disorders», Neurotherapeutics 12 (October 2015): 825–836.
25. S. Jazayeri, M. Tehrani-Doost, S. A. Keshavarz, et al., «Comparison of Therapeutic Effects of Omega-3 Fatty Acid Eicosapentaenoic Acid and Fluoxetine, Separately and in Combination, in Major Depressive Disorder», New Zealand Journal of Psychiatry 42 (July 2009): 192–198.
26. M. Friedman, «Chemistry, Nutrition, and Health-Promoting Properties of Hericium erinaceus (Lion’s Mane) Mushroom Fruiting Bodies and Mycelia and Their Bioactive Compounds», Journal of Agricultural and Food Chemistry 19 (August 2015): 7108–7123.
27. Federico Brandalise, V. Cesaroni, A. Gregori, et al., «Dietary Supplementation of Hericium erinaceus Increases Mossy Fiber-CA3 Hippocampal Neurotransmission and Recognition Memory in Wild-Type Mice», Evidence Based Complementary and Alternative Medicine (2017).
28. K. Mori, S. Inatomi, K. Ouchi, Y. Azumi, and T. Tuchida, «Improving Effects of the Mushroom Yamabushitake (Hericium erinaceus) on Mild Cognitive Impairment: A Double-Blind Placebo-Controlled Trial», Phytotherapy Research 23 (March 2009): 367–372.
29. M. Moss, J. Cook, K. Wesnes, and P. Duckett, «Aromas of Rosemary and Lavender Essential Oils Differentially Affect Cognition and Mood in Healthy Adults», International Journal of Neuroscience 113 (January 2003): 15–38.
30. A. Cieza, P. Maier, and E. Pöppel, «Effects of Ginkgo Biloba on Mental Functioning in Healthy Volunteers», Archives of Medical Research 34 (September – October 2003): 373–381.
31. Georgia Ede, «Ketogenic Diets for Psychiatric Disorders: A New 2017 Review», Psychology Today, June 30, 2017, https: / / www.psychologytoday.com / us / blog / diagnosis-diet / 201706 / ketogenic-diets-psychiatric-disorders-new-2017-review.
ГЛАВА 9.
Кетоз – супергерой для гормонов
1. Centers for Disease Control and Prevention, «PCOS and Diabetes, Heart Disease, Stroke», last updated March 14, 2018, https: / / www.cdc.gov / diabetes / library / spotlights / pcos.html.
2. John C. Mavropoulos, William S. Yancy, Juanita Hepburn, and Eric C Westman, «The Effects of a Low-Carbohydrate, Ketogenic Diet on the Polycystic Ovary Syndrome: A Pilot Study», Nutrition & Metabolism 2 (December 2005).
3. K. Yank, Liuting Zeng, Tingting Bao, and Jinwen Ge, «Effectiveness of Omega-3 Fatty Acid for Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis», Reproductive Biology and Endocrinology 16 (March 2018).
4. S. Kalgaonkar, R. U. Almario, D. Gurusinghe, et al., «Differential Effects of Walnuts vs. Almonds on Improving Metabolic and Endocrine Parameters in PCOS», European Journal of Clinical Nutrition 65 (March 2011): 386–393.
5. Debra A. Nowak, D. C. Snyder, A. J. Brown, and W. Demark-Wahnefried, «The Effect of Flaxseed Supplementation on Hormone Levels Associated with Polycystic Ovary Syndrome: A Case Study», Current Topics in Nutraceutical Research 5 (2007): 177–181.
6. Ming-Wei Lin and Meng-Hsing Wu, «The Role of Vitamin D in Polycystic Ovary Syndrome», Indian Journal of Medical Research 142 (September 2015):
